Back
Anglo American Platinum Vs. Ultragenyx Pharmaceutical Industry Stock Comparison
Sell
11
ANGPY
Anglo American Platinum
Last Price:
5.40
Seasonality Move:
0.58%
Sell
47
RARE
Ultragenyx Pharmaceutical
Last Price:
41.06
Seasonality Move:
-0.9%
Sell
11
Anglo American Platinum (ANGPY)
is a Sell
Is Anglo American Platinum a Buy, Sell or Hold?
- The current Anglo American Platinum [ANGPY] share price is $5.29. The Score for ANGPY is 11, which is 78% below its historic median score of 50, and infers higher risk than normal.
- ANGPY is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
47
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?
- The current Ultragenyx Pharmaceutical [RARE] share price is $41.42. The Score for RARE is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ANGPY Stock Price Chart
What is Anglo American Platinum's stock price today?
-
The Anglo American Platinum share price today is $5.29
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ANGPY is experiencing slight buying pressure.
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical's stock price today?
-
The Ultragenyx Pharmaceutical share price today is $41.42
The current trend is relatively stagnant and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.
ANGPY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.16 | Sell |
Relative Strength Index (14 RSI): | 39.59 | Sell |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (5.21 - 6.05) | Sell |
Bollinger Bands (100): | (5.77 - 6.99) | Sell |
RARE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.45 | Sell |
Relative Strength Index (14 RSI): | 52.47 | Buy |
Chaikin Money Flow: | 873891 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (38.82 - 42.02) | Buy |
Bollinger Bands (100): | (40.78 - 48.78) | Sell |
ANGPY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 5.58 | Sell |
20-day SMA: | 5.44 | Sell |
50-day SMA: | 6.05 | Sell |
200-day SMA: | 6.53 | Sell |
8-day EMA: | 5.53 | Sell |
20-day EMA: | 5.63 | Sell |
50-day EMA: | 5.98 | Sell |
200-day EMA: | 6.88 | Sell |
RARE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 39.5 | Buy |
20-day SMA: | 40.58 | Buy |
50-day SMA: | 41.51 | Sell |
200-day SMA: | 42.46 | Sell |
8-day EMA: | 40.23 | Buy |
20-day EMA: | 40.49 | Buy |
50-day EMA: | 41.77 | Sell |
200-day EMA: | 43.33 | Sell |
Anglo American Platinum Earnings Growth & ANGPY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.51 per share, an increase next quarter of $0.03 per share, an increase this year of $0.94 per share, and an increase next year of $1.06 per share.
Anglo American Platinum Technical Analysis
Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Ultragenyx Pharmaceutical Technical Analysis
Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |